A comprehensive view of capsules / pills / tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Ascend Labs recalls 10 lots of dabigatran etexilate anticoagulant capsules in US after routine test finds suspected carcinogen N-nitroso-dabigatran; products shipped between June 2022 and October 2022
Published: March 23, 2023 by FiercePharma
Pfizer recalls 4.2 million units of prescription Nurtec ODT 75 mg orally disintegrating migraine therapy tablets sold in cartons containing one blister card of 8 tablets; drug package does not meet child-resistant packaging requirements
Published: March 16, 2023 by CE Noticias Financieras
FDA briefing document finds clinical trial results of Pfizer’s Paxlovid COVID-19 antiviral pill support drug’s use in high-risk adults; FDA meeting Thursday to discuss recommending full approval of Paxlovid as COVID-19 treatment
Published: March 15, 2023 by Baystreet US News Alerts
Dr Reddy's Laboratories recalling 4,320 bottles of Tacrolimus Capsules in the US due to ‘Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules,’ according to FDA enforcement report
Published: March 07, 2023 by Free Press Journal (India)
Janssen submits NDA to the US FDA seeking approval of niraparib and abiraterone acetate dual-action tablet, plus prednisone, as a first-line targeted treatment for patients with BRCA-positive metastatic castration-resistant prostate cancer
Published: March 01, 2023 by Johnson & Johnson Services Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count